Inspire Advisors LLC Lowers Stock Holdings in Amdocs Limited $DOX

Inspire Advisors LLC lowered its holdings in Amdocs Limited (NASDAQ:DOX) by 13.4% in the second quarter, HoldingsChannel reports. The firm owned 4,919 shares of the technology company’s stock after selling 763 shares during the quarter. Inspire Advisors LLC’s holdings in Amdocs were worth $449,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. LSV Asset Management boosted its holdings in shares of Amdocs by 6.6% in the 2nd quarter. LSV Asset Management now owns 3,391,510 shares of the technology company’s stock valued at $309,441,000 after buying an additional 211,009 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH grew its position in shares of Amdocs by 22.9% during the second quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 114,540 shares of the technology company’s stock worth $10,451,000 after acquiring an additional 21,378 shares during the last quarter. Cetera Investment Advisers increased its holdings in shares of Amdocs by 9.5% in the 2nd quarter. Cetera Investment Advisers now owns 67,500 shares of the technology company’s stock valued at $6,159,000 after acquiring an additional 5,860 shares during the period. Creative Planning raised its position in Amdocs by 40.2% in the 2nd quarter. Creative Planning now owns 30,524 shares of the technology company’s stock valued at $2,785,000 after purchasing an additional 8,755 shares during the last quarter. Finally, Police & Firemen s Retirement System of New Jersey boosted its stake in Amdocs by 4.3% during the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 42,572 shares of the technology company’s stock worth $3,884,000 after purchasing an additional 1,769 shares during the period. 92.02% of the stock is owned by institutional investors and hedge funds.

Amdocs Stock Down 0.8%

DOX opened at $75.39 on Thursday. The firm has a market cap of $8.51 billion, a P/E ratio of 15.29, a PEG ratio of 1.40 and a beta of 0.51. The business’s fifty day simple moving average is $82.45 and its 200 day simple moving average is $86.98. Amdocs Limited has a 52 week low of $74.32 and a 52 week high of $95.41. The company has a quick ratio of 1.22, a current ratio of 1.22 and a debt-to-equity ratio of 0.23.

Amdocs (NASDAQ:DOX) last announced its earnings results on Tuesday, November 11th. The technology company reported $1.83 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.82 by $0.01. The firm had revenue of $1.15 billion for the quarter, compared to analyst estimates of $1.15 billion. Amdocs had a net margin of 11.94% and a return on equity of 19.66%. Amdocs’s revenue was down 9.0% compared to the same quarter last year. During the same quarter last year, the business earned $1.70 earnings per share. Amdocs has set its FY 2026 guidance at 7.270-7.550 EPS. Q1 2026 guidance at 1.730-1.790 EPS. As a group, equities research analysts anticipate that Amdocs Limited will post 6.21 EPS for the current fiscal year.

Amdocs Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Wednesday, December 31st will be paid a dividend of $0.527 per share. The ex-dividend date of this dividend is Wednesday, December 31st. This represents a $2.11 dividend on an annualized basis and a dividend yield of 2.8%. Amdocs’s dividend payout ratio is currently 41.58%.

Wall Street Analyst Weigh In

DOX has been the subject of a number of recent research reports. Stifel Nicolaus decreased their price objective on Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research report on Wednesday, November 12th. Bank of America cut their price target on Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research note on Wednesday, November 12th. Wall Street Zen lowered shares of Amdocs from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Wolfe Research reissued a “peer perform” rating on shares of Amdocs in a research note on Thursday, November 13th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Amdocs in a research note on Thursday, October 30th. Two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $97.00.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.